 |
市场调查报告书
商品编码
1907939
基因改造动物市场按动物类型、技术、应用、疾病领域、最终用户和地区划分Transgenic Animal Market, By Animal Type, By Technology, By Application, By Disease Area, By End User, By Geography |
||||||
基因改造动物市场预计到 2025 年价值 39.6 亿美元，预计到 2032 年将达到 79.2 亿美元，2025 年至 2032 年的复合年增长率为 10.4%。
| 分析范围 | 分析详情 | ||
|---|---|---|---|
| 基准年 | 2024 | 市场规模（2025 年） | 39.6亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期（2025-2032 年）复合年增长率 | 10.40% | 预计金额（2032 年） | 79.2亿美元 |
全球基因改造动物（基因改造动物）市场是生物技术和製药行业的创新领域，涉及用于科学研究、药物开发和治疗应用的基因工程动物。基因改造动物透过基因工程技术製造，携带外源基因或经过改造的内源基因，使研究人员能够研究人类疾病、测试潜在治疗方法并开发新的治疗方法。这些动物是理解复杂生物过程、遗传疾病和疾病机制的重要活体模型，而这些过程、疾病和机制在传统的实验室环境中是无法重现的。
这个市场主要包括基因转殖小鼠、大鼠、兔子、猪和其他专为生物医学研究、药物测试和学术研究而专门设计的实验动物。由于对个人化医疗的需求不断增长、遗传疾病的盛行率上升以及生物技术研究投入的增加，基因改造动物市场正经历显着增长。该产业在加速药物研发进程、缩短新疗法上市时间以及透过更精准的临床前测试模型提高临床试验成功率方面发挥着至关重要的作用。
市场动态
全球基因改造动物市场受多种强劲因素驱动，持续推动其在製药和生物技术领域的扩张。关键成长要素包括对个人化医疗和标靶治疗日益增长的需求，这需要先进的动物模型来了解个别基因变异和治疗反应。遗传性疾病、癌症、糖尿病和神经系统疾病的日益普遍，促使人们需要精准的疾病模型，而基因改造动物恰好能够提供这种模型。生物技术研发投入的不断增加，以及政府对基因组研究的资助，为市场成长奠定了坚实的基础。
基因改造动物在药物发现和开发过程中的广泛应用显着缩短了新药上市的时间并降低了成本，使其成为製药公司不可或缺的工具。然而，基因改造动物的应用仍存在许多局限性，包括严格的动物实验监管、动物基因改造的伦理问题以及建构和维护基因改造动物族群的高成本。复杂的繁殖程序、特殊的饲养条件以及对专业技术人员的需求也为操作带来了挑战。
此外，诸如晶片器官技术和电脑建模等替代检测方法的出现也构成了潜在的竞争威胁。儘管存在这些挑战，但仍存在巨大的机会，包括生物技术研究快速发展的新兴市场、用于培育抗病牲畜的不断扩大的农业应用，以及基因治疗和再生医学研究等新兴治疗领域对转基因动物日益增长的需求。
本报告的主要特点
- 本报告对全球基因改造动物市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和复合年增长率。
- 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
- 全球基因改造动物市场的主要企业将根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务绩效和策略。
- 本报告提供的见解将使负责人和公司经营团队能够就未来的产品发布、产品更新、市场扩张和行销策略做出明智的决策。
- 《全球基因改造动物市场》报告面向该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过各种用于分析全球基因改造动物市场的策略矩阵，更轻鬆地做出决策。
目录
第一章 分析目标与先决条件
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章：市场动态、监管与趋势分析
- 市场动态
- 司机
- 抑制因素
- 机会
- 影响分析
- 重大进展
- 监管情景
- 产品上市/核准
- PEST分析
- 波特五力分析
- 企业合併情景
- 产业趋势
4. 全球基因改造动物市场（按动物类型划分）（2020-2032 年）
- 老鼠
- 鼠
- 斑马鱼
- 猪
- 牛
- 羊
- 山羊
- 鸡
- 其他（非人灵长类、兔子）
5. 全球基因改造动物市场依技术划分（2020-2032 年）
- 显微注射
- 胚胎干细胞（ESC）注射
- 核移植（克隆技术）
- CRISPR/Cas9 和其他基因编辑技术
- 病毒载体介导的转基因
6. 全球基因改造动物市场依应用领域划分（2020-2032 年）
- 生物医学研究
- 药物发现与开发
- 毒性和安全性测试
- 疾病模型
- 再生医学
- 异种移植
- 生物製药生产
- 农业性状改良
7. 全球基因改造动物市场依疾病领域划分（2020-2032 年）
- 瘤
- 神经系统疾病
- 心血管疾病
- 代谢性疾病
- 免疫性疾病，自体免疫疾病
- 遗传和罕见疾病
- 感染疾病
8. 全球基因改造动物市场（以最终用户划分）（2020-2032 年）
- 学术和研究机构
- 製药公司
- 生技公司
- CRO（委外研发机构）
- 农业研究机构
- 政府和监管机构实验室
9. 全球基因改造动物市场区域分析（2020-2032 年）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中非
第十章 竞争格局
- Charles River Laboratories
- Taconic Biosciences
- genOway
- Cyagen Biosciences
- Biocytogen
- Transgenic Inc
- Ozgene
- PolyGene
- Hera BioLabs
- Ingenious Targeting Laboratory
- Applied StemCell
- GemPharmatech
- Harbour BioMed
- Crown Bioscience
- Pharmaron
第十一章 分析师建议
- 机会
- 分析师观点
- Coherent Opportunity Map (COM)
第十二章 参考文献与分析方法
- 参考
- 分析方法
- 关于 Coherent Market Insights
Transgenic Animal Market is estimated to be valued at USD 3.96 Bn in 2025 and is expected to reach USD 7.92 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.96 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.40% | 2032 Value Projection: | USD 7.92 Bn |
The global transgenic animal market represents a revolutionary segment within biotechnology and pharmaceutical industries, encompassing genetically modified animals engineered for scientific research, drug development, and therapeutic applications. Transgenic animals, created through genetic engineering techniques, carry foreign genes or modified endogenous genes that enable researchers to study human diseases, test potential treatments, and develop novel therapeutic approaches. These animals serve as crucial living models for understanding complex biological processes, genetic disorders, and disease mechanisms that would be impossible to replicate in traditional laboratory settings.
The market primarily includes transgenic mice, rats, rabbits, pigs, and other laboratory animals specifically designed for biomedical research, pharmaceutical testing, and academic studies. With increasing demand for personalized medicine, growing prevalence of genetic disorders, and rising investments in biotechnology research, the transgenic animal market has experienced significant growth. The industry plays a pivotal role in accelerating drug discovery processes, reducing time-to-market for new therapeutics, and enhancing the success rates of clinical trials through more accurate pre-clinical testing models.
Market Dynamics
The global transgenic animal market is driven by several compelling factors that continue to propel its expansion across pharmaceutical and biotechnology sectors. Primary growth drivers include the escalating demand for personalized medicine and targeted therapies, which require sophisticated animal models to understand individual genetic variations and treatment responses. The increasing prevalence of genetic disorders, cancer, diabetes, and neurological diseases has intensified the need for accurate disease models that transgenic animals uniquely provide. Rising investments in biotechnology research and development, coupled with government funding for genomic studies, have created a robust foundation for market growth.
The growing adoption of transgenic animals in drug discovery and development processes significantly reduces the time and cost associated with bringing new medications to market, making them indispensable tools for pharmaceutical companies. However, the market faces notable restraints including stringent regulatory frameworks governing animal research, ethical concerns surrounding genetic modification of animals, and high costs associated with developing and maintaining transgenic animal colonies. Complex breeding procedures, specialized housing requirements, and skilled personnel needs contribute to operational challenges.
Additionally, the emergence of alternative testing methods such as organ-on-chip technologies and computer modeling presents potential competitive threats. Despite these challenges, substantial opportunities exist in emerging markets where biotechnology research is expanding rapidly, increasing applications in agriculture for developing disease-resistant livestock, and growing demand for transgenic animals in emerging therapeutic areas including gene therapy and regenerative medicine research.
Key Features of the Study
- This report provides in-depth analysis of the global transgenic animal market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global transgenic animal market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Charles River Laboratories, Taconic Biosciences, genOway, Cyagen Biosciences, Biocytogen, Transgenic Inc, Ozgene, PolyGene, Hera BioLabs, Ingenious Targeting Laboratory, Applied StemCell, GemPharmatech, Harbour BioMed, Crown Bioscience, and Pharmaron
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global transgenic animal market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transgenic animal market
Market Segmentation
- Animal Type Insights (Revenue, USD Bn, 2020 - 2032)
- Mice
- Rats
- Zebrafish
- Pigs
- Cattle
- Sheep
- Goats
- Chickens
- Others (Non-human primates rabbits)
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Microinjection
- Embryonic Stem Cell (ESC) Injection
- Nuclear Transfer (Cloning)
- CRISPR/Cas9 and Other Gene Editing Technologies
- Viral Vector-mediated Transgenesis
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Biomedical Research
- Drug Discovery and Development
- Toxicology and Safety Testing
- Disease Modeling
- Regenerative Medicine
- Xenotransplantation
- Biopharmaceutical Production
- Agricultural Trait Enhancement
- Disease Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurological Disorders
- Cardiovascular Diseases
- Metabolic Disorders
- Immunological and Autoimmune Diseases
- Genetic and Rare Diseases
- Infectious Diseases
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Agricultural Research Organizations
- Government and Regulatory Laboratories
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- Taconic Biosciences
- genOway
- Cyagen Biosciences
- Biocytogen
- Transgenic Inc
- Ozgene
- PolyGene
- Hera BioLabs
- Ingenious Targeting Laboratory
- Applied StemCell
- GemPharmatech
- Harbour BioMed
- Crown Bioscience
- Pharmaron
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Transgenic Animal Market, By Animal Type
- Global Transgenic Animal Market, By Technology
- Global Transgenic Animal Market, By Application
- Global Transgenic Animal Market, By Disease Area
- Global Transgenic Animal Market, By End User
- Global Transgenic Animal Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Transgenic Animal Market, By Animal Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Zebrafish
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pigs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Goats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chickens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Non-human primates rabbits)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Transgenic Animal Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Microinjection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Embryonic Stem Cell (ESC) Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nuclear Transfer (Cloning)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- CRISPR/Cas9 and Other Gene Editing Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Viral Vector-mediated Transgenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Transgenic Animal Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biomedical Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Toxicology and Safety Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Disease Modeling
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Xenotransplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biopharmaceutical Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Agricultural Trait Enhancement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Transgenic Animal Market, By Disease Area, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunological and Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Genetic and Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Transgenic Animal Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Agricultural Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government and Regulatory Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Transgenic Animal Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taconic Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- genOway
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyagen Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocytogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Transgenic Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ozgene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PolyGene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hera BioLabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ingenious Targeting Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Applied StemCell
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GemPharmatech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harbour BioMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pharmaron
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
基因改造动物市场－全球产业规模、份额、趋势、机会和预测：按产品、PCR、技术、应用、模式生物、最终用户、地区和竞争格局划分，2021-2031年
水解动物性蛋白质市场规模、份额及成长分析（按类型、形态、应用和地区划分）－2026-2033年产业预测
动物性蛋白质市场规模、份额及成长分析（按类型、形式、应用和地区划分）－产业预测（2026-2033）
动物性蛋白质配料市场规模、份额及成长分析（按产品、形式、应用和地区划分）－产业预测（2026-2033 年）
加工动物性蛋白质市场预测（至 2032 年）：按产品类型、动物来源、加工方法、形态、应用、最终用户和地区进行的全球分析
功能性动物性蛋白质市场：未来预测（2025-2030）
加工动物性蛋白质市场分析及预测（至2034年）：类型、产品、应用、技术、成分、最终用户、製程、配方、设备、解决方案
动物性蛋白质市场规模、占有率、预测、趋势分析：按类型、形式、应用- 2031 年全球预测
全球动物性蛋白质市场水解动物性蛋白质的全球市场